Catherine Rice
Catherine Rice's purchase track record
Catherine Rice has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/16/2022 | BRSP | $50K | +16.9% | +1.0% | +6.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Urban Edge: UBS Lowers Target to $21, Cash Flow Discount Questioned. UBS has lowered its price target for Urban Edge to $21 and kept a neutral outlook. Analysts are also questioning whether the stock is trading at a discount to its cash flow. The shares are near a key support level of $21.37 and have a low RSI of 25.3, indicating potential buying pressure.
Transaction History
| BRSP | ▲ Buy | Grant | 22,085 | $0 | 5/20/2026 | View on chart |
| UE | ▲ Buy | Grant | 5,710 | $125K | 5/6/2026 | View on chart |
| BRSP | ▲ Buy | Grant | 18,588 | $0 | 5/19/2025 | View on chart |
| UE | ▲ Buy | Grant | 6,776 | $125K | 5/7/2025 | View on chart |
| BRSP | ▲ Buy | Grant | 15,899 | $0 | 5/17/2024 | View on chart |
| UE | ▲ Buy | Grant | 7,036 | $120K | 5/6/2024 | View on chart |
| BRSP | ▲ Buy | Grant | 18,657 | $0 | 5/17/2023 | View on chart |
| UE | ▲ Buy | Grant | 8,293 | $120K | 5/3/2023 | View on chart |
| UE | ▲ Buy | Grant | 8,352 | $116K | 3/15/2023 | View on chart |
| BRSP | ▲ Buy | Open Market | 7,000 | $50K | 6/16/2022 | View on chart |
| BRSP | ▲ Buy | Grant | 12,438 | $0 | 5/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BrightSpire Capital lags CCC-rated bonds by 56%
A recent analysis highlights that BrightSpire Capital's stock has underperformed even low-grade corporate bonds by a wide margin. This significant relative weakness suggests investors are pricing in substantial credit risk for the company. The stock currently trades near its 52-week low, reflecting the market's cautious stance on the firm's financial health.
BrightSpire Capital lags CCC-rated bonds by 56%. A recent analysis highlights that BrightSpire Capital's stock has underperformed even low-grade corporate bonds by a wide margin. This significant relative weakness suggests investors are pricing in substantial credit risk for the company. The stock currently trades near its 52-week low, reflecting the market's cautious stance on the firm's financial health.